Cite
HARVARD Citation
Wu, J. et al. (2020). Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs. Cell proliferation. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, J. et al. (2020). Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs. Cell proliferation. p. n/a. [Online].